Structured evidence table for Lactoferrin Immune Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Lactoferrin Immune Randomized Trial | As an integral component of the human diet, dairy products are rich in high-quality protein, lactoferrin, conjugated linoleic acid, calcium, vitamin D, and various other nutrients and bioactive compounds. | 4 | Wang M (2026) | A narrative review of nutritional components, health effects, and disease prevention mechanisms of dairy products. |
| Lactoferrin Immune Randomized Trial | They exert broad health benefits through core mechanisms involving multiple pathways and targets. | 4 | Wang M (2026) | A narrative review of nutritional components, health effects, and disease prevention mechanisms of dairy products. |
| Lactoferrin Immune Randomized Trial | The PICOS question was: 'Are lactoferrin levels different between individuals with periodontitis and periodontally healthy controls, and are these levels associated with disease severity and established clinical periodontal indicators, supporting their role as diagnostic or prognostic biomarkers for periodontitis?'. | 4 | Patil GV (2026) | Role of lactoferrin in periodontal disease: A meta-analytical assessment of its reliability as a biomarker. |
| Lactoferrin Immune Randomized Trial | Egger's regression test produced a t-statistic of -0.646 (P=0.529), reflecting a lack of significant evidence for publication bias. | 4 | Patil GV (2026) | Role of lactoferrin in periodontal disease: A meta-analytical assessment of its reliability as a biomarker. |
| Lactoferrin Immune Randomized Trial | In conclusion, lactoferrin showed potential as a biomarker for periodontal disease, with elevated levels consistently linked to its presence and disease severity. | 4 | Patil GV (2026) | Role of lactoferrin in periodontal disease: A meta-analytical assessment of its reliability as a biomarker. |
| Lactoferrin Immune Randomized Trial | The present systematic review and meta-analysis assessed the clinical utility of lactoferrin as a biomarker for periodontitis by evaluating its association with established periodontal parameters, including probing pocket depth (PPD), clinical attachment loss (CAL) and gingival index (GI). | 4 | Patil GV (2026) | Role of lactoferrin in periodontal disease: A meta-analytical assessment of its reliability as a biomarker. |
Source documents